| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.235 | 5.364 | 5.466 | 3.948 | 2.913 | 1.147 | 2.610 | 2.634 | 2.798 | 3.195 |
| Total Income - EUR | 8.126 | 5.515 | 5.578 | 3.948 | 2.913 | 1.147 | 2.610 | 2.634 | 2.798 | 3.205 |
| Total Expenses - EUR | 3.162 | 4.280 | 5.132 | 3.313 | 2.034 | 1.981 | 2.053 | 2.190 | 2.598 | 2.767 |
| Gross Profit/Loss - EUR | 4.964 | 1.235 | 446 | 635 | 880 | -834 | 557 | 444 | 200 | 438 |
| Net Profit/Loss - EUR | 4.841 | 1.074 | 282 | 516 | 792 | -868 | 478 | 365 | 168 | 321 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Infant Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 774 | 1.757 | 1.971 | 693 | 1.469 | 557 | 1.203 | 1.373 | 1.269 | 1.651 |
| Inventories | 0 | 0 | 175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
| Cash | 774 | 1.757 | 1.796 | 693 | 1.469 | 557 | 1.203 | 1.373 | 1.269 | 1.643 |
| Shareholders Funds | 579 | 1.647 | 1.901 | 634 | 1.414 | 519 | 986 | 1.354 | 1.517 | 1.830 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 195 | 110 | 70 | 59 | 55 | 38 | 217 | 19 | 20 | 23 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Infant Medica Srl